Stay updated on MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Sign up to get notified when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision shows Revision: v3.6.0. Additionally, the recruitment status was updated to 'No longer looking for participants', signaling that enrollment for this study has closed.
    Difference
    0.4%
    Check dated 2026-06-13T16:25:18.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, indicating a backend content-management update that does not change the displayed study information.
    Difference
    0.1%
    Check dated 2026-06-06T12:25:21.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.4, indicating a minor platform update on the page. The update does not alter the study details or other content displayed.
    Difference
    0.1%
    Check dated 2026-05-15T23:28:26.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page’s footer revision indicator is updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change without modifying the study content displayed.
    Difference
    0.1%
    Check dated 2026-04-24T16:51:02.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:45:38.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.5.0 and removed Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T21:57:02.000Z thumbnail image

Stay in the know with updates to MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.